// App-Quantinova.ai

3347 : Allogeneic Hematopoietic Stem Cell Transplant Versus No Transplant in Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission and Complete Molecular Remission

Researchers

Presenter

  • Armin Ghobadi

Principal Investigators

  • Kahee A Mohammed

  • Rawan Faramand

  • Hagop M. Kantarjian

  • Elias Jabbour

  • Nicholas J. Short

  • Feng Gao

  • Geoffrey L Uy

  • Peter Westervelt

  • John F. DiPersio

  • Richard E. Champlin

  • Farhad Ravandi

  • Partow Kebriaei

Medical Centers

  • Washington University School of Medicine, St. Louis, MO

  • Moffitt Cancer Ctr Univ of S Florida, Tampa, FL

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A